dr peter attia semaglutide Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent [AMA 45 sneak peek] 398 ‒ AMA #86: GLP-1
Description
People are suing Novo Nordisk and Eli Lilly and Company due to legal issues surrounding their GLP-1 receptor agonist drugs, with plaintiffs bringing forth substantially similar allegations against both drug manufacturers
![dr peter attia semaglutide Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent [AMA 45 sneak peek] 398 AMA #86: GLP-1](https://peterattiamd.com/wp-content/uploads/2024/11/peter-attia-modal.jpg)
CVS Health acquired Caremark in 2007, creating the first major PBM-pharmacy chain vertical
For the ketogenic diet, caution is needed with pancreatitis, liver disease, disorders of fat metabolism, and certain kidney conditions
![dr peter attia semaglutide Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent [AMA 45 sneak peek] 398 AMA #86: GLP-1](https://i.ytimg.com/vi/Se9wYzH--L0/hqdefault.jpg)
ACG Case Rep J 2022;9:e00795
Losing your drive for it can feel like losing a relationship
![dr peter attia semaglutide Pros and cons of GLP-1 weight loss drugs and metformin as a geroprotective agent [AMA 45 sneak peek] 398 AMA #86: GLP-1](https://assets.dexa.ai/image/upload/c_fill,g_auto,q_auto:good,f_auto,dpr_2,d_entities:placeholders:chunk_kcb7v8.png,ar_5:6/entities/chunks/chunk_58028)
Davies MJ, DAlession DA, Fradkin J, et al